Titan Bio-Tech Board of Directors
Get the latest insights into the leadership at Titan Bio-Tech. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Naresh Singla | Managing Director |
| Suresh Chand Singla | Managing Director |
| Raja Singla | Whole Time Director |
| Shivom Singla | Whole Time Director |
| Udit Singla | Whole Time Director |
| Manju Singla | Non Independent & Non Executive Director |
| Supriya Singla | Non Independent & Non Executive Director |
| Rohit Jain | Chairman |
| Abhishek Agarwal | Non Executive Independent Director |
| Dhairya Madan | Non Executive Independent Director |
| Brijesh Kumar Singh | Non Executive Independent Director |
| Debendra Kumar Sabat | Non Executive Independent Director |
| Charanjit Singh | Company Secretary & Compliance Officer, Nodal Officer |
Titan Bio-Tech FAQs
The board at Titan Bio-Tech consists of experienced professionals, including Naresh Singla, Suresh Chand Singla, and others, overseeing the company’s strategic and corporate governance.
Directors at Titan Bio-Tech are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Naresh Singla is the current chairman at Titan Bio-Tech.
Executive directors at Titan Bio-Tech are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Titan Bio-Tech adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Titan Bio-Tech, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.
Titan Bio-Tech Associated Pages
